Carter's (CRI) PT Lowered to $100 at Monness, Crespi, Hardt
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $33.15 +2.28%
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Monness, Crespi, Hardt analyst Jim Cartier lowered the price target on Carter's (NYSE: CRI) to $100.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Cellnex Telecom (CLNX:SM) (CLNXF) to Sell
- Climb Bio (CLYM) PT Raised to $32 at BTIG
- Goldman Sachs Downgrades Elisa Oyj (ELISA:FH) (ELMUY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
